611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Metabolomic Profiles Differ With Macular DegenerationExtended Thromboprophylaxis Safe, Effective After Liver SurgeryExercise May Stem Kidney Damage in Lupus PatientsMinorities Exposed to Dirtier Air, U.S. Study FindsDoctors Eye the Danger From 'Nerf' GunsHealth Tip: Preventing Food Allergies While Dining OutIt's a Food Allergy! Where's the School Nurse?Lower Mortality Risk Seen With Statin Use in Older MenSleep Quality, Duration Linked to CKD ProgressionSelena Gomez's Kidney Transplant Puts Lupus Center StageVision Problems Common in Babies Infected With ZikaSmoking, Poor Diet Lead Global Death CausesWhich Single Behavior Best Prevents High Blood Pressure?Traces of Tattoo May Reach the Lymph NodesVitamin D Deficiency Tied to Neuropathic Pain'Upside' to Diabetes Really Isn'tSemen Harbors Wide Range of VirusesHeath Tip: Contact Lenses Aren't Risk-FreeDiabetes Threatens Kidneys, Vision of Millions of AmericansNew Guideline Aims to Help Doctors Diagnose Head, Neck Masses'Microbiomes' May Hold Key to Kids' Ear InfectionsWarfarin, Rivaroxaban Similarly Safe, EffectiveHealth Tip: Leading Causes of Food PoisoningER Visits for These 3 Health Woes Don't Have to Happen'Modest at Best' Discriminatory Ability for CBC Test in InfantsDo E-Cigarettes Damage Blood Vessels?'Healthy' Obese Still Face Higher Heart RisksTake a Stand Against Sitting Too MuchGreater Height Tied to Higher Risk of Venous ThromboembolismZika Virus Preferentially Targets Glioblastoma Stem CellsBiomarkers Can Predict Rapid Drop in Renal Function in T2DMPeople Picking Up Infection From Pet Store Puppies' Poop: CDCHeath Tip: Getting Rid of Head LiceThe Health Risks of Long Work WeeksLupus Hits Certain Groups HarderSocioeconomic Conditions Affect Metabolic Syndrome RiskAirway Mucin Concentrations May Help Predict Chronic BronchitisCenter Surgical Volume Linked to LVAD Patient OutcomesGuinea Pigs Harbor a Hidden Health HazardHealth Tip: Antibiotic-Resistant BacteriaFor City Kids With Asthma, Nearby Green Space Is KeyThe Best Way to Diagnose a Food AllergyBudget Cuts Threaten Research on Antimicrobial ResistanceIntensive BP Control Associated With Increased CKD RiskNo Easy Road Back for Ebola SurvivorsReduced Asthma Exacerbations Seen With TezepelumabEarly Respiratory Infections Tied to Celiac in High-Risk ChildrenStatins Help Healthy People Lower Their 'Bad' CholesterolRemember This: A Healthy Body Keeps the Mind Sharp, TooAcid Reflux? Try Going Vegetarian
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

β-2 Adrenergic Agonists May Help Fight Parkinson's Disease


HealthDay News
Updated: Sep 1st 2017

new article illustration

FRIDAY, Sept. 1, 2017 (HealthDay News) -- β-2 adrenergic agonists might be able to combat Parkinson's disease, according to a study published in the Sept. 1 issue of Science.

Clemens Scherzer, M.D., a neurologist at Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues discovered the β2-adrenoreceptor is a regulator of the α-synuclein gene. The researchers then analyzed a Norwegian database that tracks all drug prescriptions in that country.

Out of four million people, the team identified 619,863 who'd used salbutamol. Overall, those people were one-third less likely to develop Parkinson's over 11 years, versus non-users. In contrast, Parkinson's risk was doubled among people who'd ever used propranolol. The researchers found that β-blockers may actually increase activity in the alpha-synuclein gene.

"Our study presents a path to drug development that is distinct from traditional approaches. Targeting the endogenous expression of a human disease gene may be a useful strategy for other diseases attributed to copy number variation or regulatory variants," the authors write. "The drug development pipeline tested in this study could be more generally applicable to rapid discovery and translation of therapeutics for other brain diseases."

Abstract/Full Text (subscription or payment may be required)